HTGMQ (HTGMQ) Stock Price & Analysis
HTGMQ (HTGMQ) rose 0.00% to USD 0 as of June 10, 2026 at 09:40 UTC, according to Nexqual real-time market data.
HTGMQ last closed at USD 0; the session ranged USD 0–0 on volume of 125 shares. Market capitalization is $221, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 09:40 UTC.
Key Statistics (as of June 10, 2026 at 09:40 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 125 shares |
| Market Cap | $221 |
| Exchange | PNK |
Technical Analysis (HTGMQ)
Nexqual's technical model rates HTGMQ "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 09:40 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (HTGMQ)
Wall Street analysts rate HTGMQ "None", per Nexqual as of June 10, 2026 at 09:40 UTC.
| Consensus Rating | None |
|---|
Earnings (HTGMQ)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2023-03-31 | USD -2.28 vs est -1.94 ▼ miss |
| 2022-12-31 | USD -3.16 vs est -2.41 ▼ miss |
| 2022-09-30 | USD -4.92 vs est -6.42 ▲ beat |
| 2022-06-30 | USD -6.48 vs est -7.8 ▲ beat |
Source: Nexqual, June 10, 2026 at 09:40 UTC.
Financials & Fundamentals (HTGMQ)
| Total Revenue | $6.21M |
|---|---|
| Revenue Growth (YoY) | -12.80% |
| Gross Margin | -79.14% |
| Operating Margin | -485.48% |
| Profit Margin | +0.00% |
| ROE | -343.21% |
| Debt / Equity | 1,643.2 |
| Current Ratio | 1.4 |
| Total Cash | $6.56M |
| Total Debt | $7.80M |
| Free Cash Flow | $-9.91M |
Source: Nexqual, June 10, 2026 at 09:40 UTC.
Financial Health Score (HTGMQ)
Nexqual rates HTGMQ's overall financial health "Critical" across five dimensions, as of June 10, 2026 at 09:40 UTC.
| Growth | Critical — Revenue -29% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Critical — $7M cash vs $8M debt |
| Cash Flow | Weak — FCF negative: -$10M, burning cash |
| Efficiency | Critical — ROE -343%, ROA -62.3% |
Ownership (HTGMQ)
| Insider Ownership | +0.02% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.21M |
| Float | 2.21M |
| Short % of Float | +0.12% |
Source: Nexqual, June 10, 2026 at 09:40 UTC.
Leadership (HTGMQ)
HTGMQ is led by John L. Lubniewski (age 61), President, CEO & Director, per Nexqual as of June 10, 2026 at 09:40 UTC.
| President, CEO & Director | John L. Lubniewski (age 61) |
|---|---|
| Senior Vice President of Finance & Administration | Laura Lee Godlewski (age 45) |
| Senior Vice President of Research & Development | Patrick C. Roche (age 72) |
| Senior Vice President of Therapeutics | Stephen A. Barat (age 55) |
| Vice President of Target Strategy & Early Development | Christina M. Carruthers |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FNAM | EVOLUTIONARY GENOMICS INC | USD 0 | ▲ 0% |
| VENZF | Venzee Technologies Inc. | USD 0.05 | ▼ 16.06% |
| CUAUF | C3 METALS INC. | USD 0.57 | ▲ 0% |
| EAWD | Energy and Water Development Co | USD 0.01 | ▲ 0% |
| IVRN | INNOVEREN SCIENTIFIC INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:40 UTC. This page is informational and not investment advice.